1. Home
  2. HCM vs BXMT Comparison

HCM vs BXMT Comparison

Compare HCM & BXMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCM
  • BXMT
  • Stock Information
  • Founded
  • HCM 2000
  • BXMT 1966
  • Country
  • HCM Hong Kong
  • BXMT United States
  • Employees
  • HCM N/A
  • BXMT N/A
  • Industry
  • HCM Biotechnology: Pharmaceutical Preparations
  • BXMT Real Estate Investment Trusts
  • Sector
  • HCM Health Care
  • BXMT Real Estate
  • Exchange
  • HCM Nasdaq
  • BXMT Nasdaq
  • Market Cap
  • HCM 2.6B
  • BXMT 3.1B
  • IPO Year
  • HCM N/A
  • BXMT N/A
  • Fundamental
  • Price
  • HCM $14.20
  • BXMT $18.44
  • Analyst Decision
  • HCM Hold
  • BXMT Buy
  • Analyst Count
  • HCM 1
  • BXMT 9
  • Target Price
  • HCM $19.00
  • BXMT $20.38
  • AVG Volume (30 Days)
  • HCM 76.1K
  • BXMT 1.9M
  • Earning Date
  • HCM 02-26-2025
  • BXMT 02-12-2025
  • Dividend Yield
  • HCM N/A
  • BXMT 10.23%
  • EPS Growth
  • HCM N/A
  • BXMT N/A
  • EPS
  • HCM N/A
  • BXMT N/A
  • Revenue
  • HCM $610,806,000.00
  • BXMT N/A
  • Revenue This Year
  • HCM N/A
  • BXMT N/A
  • Revenue Next Year
  • HCM $20.69
  • BXMT N/A
  • P/E Ratio
  • HCM N/A
  • BXMT N/A
  • Revenue Growth
  • HCM N/A
  • BXMT 1.04
  • 52 Week Low
  • HCM $11.93
  • BXMT $16.53
  • 52 Week High
  • HCM $21.92
  • BXMT $21.50
  • Technical
  • Relative Strength Index (RSI)
  • HCM 42.32
  • BXMT 55.23
  • Support Level
  • HCM $13.00
  • BXMT $16.72
  • Resistance Level
  • HCM $15.29
  • BXMT $18.55
  • Average True Range (ATR)
  • HCM 0.46
  • BXMT 0.40
  • MACD
  • HCM -0.00
  • BXMT 0.10
  • Stochastic Oscillator
  • HCM 37.74
  • BXMT 92.70

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

About BXMT Blackstone Mortgage Trust Inc.

Blackstone Mortgage Trust Inc is a real estate finance company primarily involved in the origination and purchase of senior loans collateralized by commercial properties in North America, Europe, and Australia. The vast majority of the company's asset portfolio is comprised of floating rate loans secured by priority mortgages. These mortgages are mainly derived from office, hotel, and manufactured housing properties. A significant percentage of the collateralized real estate properties are located in New York, California, and the United Kingdom. Blackstone Mortgage Trust is managed by a subsidiary of The Blackstone Group and benefits from the market data provided by its parent company. Nearly all of Blackstone Mortgage Trust's revenue is generated in the form of interest income.

Share on Social Networks: